ClinicalTrials.gov
public full text
Public Domain
LEA29Y (Belatacept) Emory Edmonton Protocol
Type 1 diabetes is an autoimmune disease in which the insulin-producing pancreatic beta cells are destroyed, resulting in poor blood sugar control. The purpose of this study is to determine the safety and effectiveness of islet transplantation using a steroid-free, calcineurin-inhibitor-free belatacept based immunosuppressive medication, for treating type 1 diabetes in individuals experiencing hypoglycemia unawareness and severe hypoglycemic episodes.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults#914958
- Comparison Between Hypoglycemic Counter Regulatory Responses in Type 1 Diabetics vs Control Subjects#257048
- Association Between Insulin Resistance and Beta Cell Function With HbA1C in Diabetics#836829
- Efficacy and Safety of Sorafenib in New-Onset Type 1 Diabetes Mellitus#1102432
- Beta Cell Function in (Pre) Type 1 Diabetes#405282
Record · ID 1321706
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive